Topcat trial wiki journal
Web1. nov 2024 · The TOPCAT (Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist) trial randomized patients with HFpEF (LVEF ≥45%) to spironolactone versus placebo and found no difference in the composite outcome of cardiovascular mortality, aborted cardiac arrest, or heart failure hospitalization ( 2 ). WebThe relationship between frailty and outcomes and the role of frailty in modulating the benefits of spironolactone were examined in a subset of 1767 TOPCAT patients. For the …
Topcat trial wiki journal
Did you know?
Web13. okt 2024 · Published in 2024, EMPEROR-Preserved trial randomized about 6,000 patients with NYHA class II-IV symptoms, LVEF >40% (i.e., HFmrEF and HFpEF), and NT-proBNP … Web9. jan 2024 · The study cohort was comprised of 1,765 participants from TOPCAT (Americas in Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial). The primary endpoint of TOPCAT was a composite of cardiovascular death, heart failure hospitalization, or aborted cardiac arrest.
WebObjective: The TOPCAT trial is designed to evaluate the effect of spironolactone, an aldosterone antagonist, on morbidity, mortality, and quality of life in patients with HF-PEF. Methods: Up to 3,515 patients with HF-PEF will be randomized in double-blind fashion to treatment with spironolactone (target dose 30 mg daily) or matching placebo. WebABSTRACT. Aims. EMPEROR-Preserved is an ongoing trial evaluating the effect of empagliflozin in patients with heart failure with preserved ejection fraction (HFpEF). This …
Web27. apr 2024 · In the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial, patients with heart failure and preserved ejection … Web1. apr 2024 · @article{Anand2024InteractionBS, title={Interaction Between Spironolactone and Natriuretic Peptides in Patients With Heart Failure and Preserved Ejection Fraction: From the TOPCAT Trial.}, author={Inder S. Anand and Brian Lee Claggett and Jiankang Liu and Amil M. Shah and Thomas S. Rector and Sanjiv J. Shah and Akshay S. Desai and Eileen O ...
Web27. aug 2024 · e new england journal o medicine n engl j med 385;16 nejm.org October 14, 2024 1451 established in 1812 October 14, 2024 vol. 385 no. 16 The authors’ full names, academic de-grees, and ...
Web12. jan 2024 · John McMurray, MBChB: One of the large trials conducted in patients with HFpEF [heart failure with preserved ejection fraction] was the TOPCAT trial, which … phone gooseneckWeb4. dec 2024 · TOPCAT indicates Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist. Figure 2. Cumulative Incidence for Heart Failure Hospitalizations by β-Blocker Use Among Patients With an Ejection Fraction of … phone gps auto holderWeb20. feb 2024 · The TOPCAT trial evaluated the effectiveness of aldosterone antagonist therapy in reducing cardiovascular mortality, aborted cardiac arrest, and heart failure … how do you measure a mortice lockWeb15. mar 2024 · The detailed design and protocol of the TOPCAT trial have been published and described previously. 10, 11 Briefly, TOPCAT was a multi‐center, international, randomized, double‐masked clinical trial that evaluated the efficacy and safety of spironolactone in 3445 patients with HFpEF. To meet the inclusion criteria for TOPCAT, … how do you measure a mountainWebThe primary outcome of the TOPCAT trial was a composite of cardiovascular mortality, aborted cardiac arrest, or heart failure hospitalization. Results: A total of 760 patients (43%) had a history of AF (18%) or AF on ECG at enrollment (25%). phone got wet and screen went blackWeb29. mar 2024 · This study randomized patients with HFpEF and either prior hospitalization for HF or elevated NP levels (B-type NP [BNP] ≥100 pg/ml or N-terminal proBNP ≥360 pg/ml) to spironolactone or placebo. Of the 3,445 patients enrolled in the TOPCAT trial, 2,464 (72%) were enrolled in the hospitalization stratum and 981 (28%) in the elevated NP stratum. phone gopro mountWeb25. feb 2024 · The study authors performed latent-class analysis to identify heart failure with preserved ejection fraction (HFpEF) phenogroups based on standard clinical features, and assessed differences in multiple biomarkers measured from frozen plasma; cardiac and arterial structure/function measured with echocardiography and arterial tonometry; … phone google locked